Deal Snapshot
LuminUltra Acquires Source Molecular, Expanding Testing Capacity
Monday 30 November 2020

Canadian biotechnology company LuminUltra has acquired US-based lab-based testing solutions provider Source Molecular Corp, the company said.

Source Molecular is a specialist in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of use cases.

Date Published: 30/11/2020